Abstract:Objective To observe the expression of leucine zipper-EF-hand containing transmembrane protein 1 ( LETM1) in gastric cancer and evaluate its prognostic value of patients with gastric cancer. Methods The expression of LETM1 in 114 cases of gastric cancer and corresponding adjacent normal tissues was detected by immunohistochemical method. The patients clinical survival prognosis information was obtained by telephone follow-up. And the relationship between LETM1 and clinicopathological features and overall survival rate of gastric cancer patients were analyzed. Results The positive rates of LETM1 in gastric cancer and its adjacent normal tissues were 59. 65% ( 68 /114) and 15. 78% ( 14 /114) ,respectively ( P < 0. 05) ,which were closely related to the differentiation degree( P = 0. 030 ) ,clinical TNM stage ( P = 0. 003 ) and lymph node metastases ( P = 0. 033 ) of tumor. The prognostic result analysis showed that the 3-year overall survival rate of gastric cancer patients with high LETM1 expression was significantly lower than that of patients with negative LETM1 expression ( χ = 6. 097,P < 0. 05 ) . The expression level of LETM1,clinical TNM stage,pathological differentiation and lymph node metastasis are independent prognostic factors,and the high expression level of LETM1,deeper extent of infiltration,higher differentiation degree,and positive lymph node metastasis could lead to poor prognosis in patients. Conclusion The abnormal expression of LETM1 is closely related to the occurrence and development of gastric cancer,which can be used as a new biomarker for early diagnosis and clinical prognosis of gastric cancer.

Expression of LETM1 in gastric cancer and its correlation with prognosis